Neoprobe Corporation to Present at Credit Suisse First Boston 2nd Annual Small & Mid Cap Conference

Published: Sep 22, 2011

DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (NYSE Amex: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that Dr. Mark Pykett, Neoprobe’s President and Chief Executive Officer, will deliver a presentation to institutional investors at 1:50 PM ET, Wednesday, September 28, 2011 at the Credit Suisse 2nd Annual Small & Mid Cap Conference, taking place at Le Parker Meridien Hotel, New York.

Back to news